Innovations in Pharmaceutical Sciences Seminar Series
PB 450
Title: Regulation of Drug Toxicity Through Manipulation of Solute Carrier Activity
Jason Sprowl, PhD, is an Assistant Professor in the Department of Pharmaceutical Sciences at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences. The overarching goal of his research program is to study the role of solute carriers and kinases as contributors to drug efficacy and toxicity. His current research efforts have largely focused on improving our understanding of the molecular regulatory mechanisms, such as post-translational modifications, that mediate activity of various solute carriers involved in drug-induced adverse events. He has published more than 30 peer-reviewed manuscripts and has received great recognition for his efforts. Jason was the recipient of the ASPET Division for Translational and Clinical Pharmacology Early Career award, the AACP new investigator award, and a competitive KL2 scholar award provided by the University at Buffalo Clinical and Translational Science Institute. His research is also currently funded by the National Institute of General Medical Sciences and the National Institute on Deafness and Other Communication Disorders.